Leidos Holdings, Inc. (LDOS)is a Virginia-basedtechnology company specializing in defense, aviation, information technology, and biomedical research.With a market cap of$23.9 billion,Leidos employs approximately 47,000 people and operates across four primary divisions: National Security & Digital, Health & Civil, Commercial & International, and Defense Systems. Theglobal science and technology leaderis expected to announce its fiscalthird-quarter earningsfor 2025 before the market opens on Tuesday, Nov. 4.
Ahead of the event, analysts expect LDOS to report aprofit of $2.62 per shareon a diluted basis,down 10.6% from$2.93 per share in the year-ago quarter. On the bright side, the company has consistently surpassed Wall Street’s EPS estimates in its last four quarterly reports.
-
Short Sellers Are Ganging Up on Beyond Meat Stock. Is There Hope for a Squeeze, or Should You Ditch BYND Now
-
If You Think AI’s A Bubble, You’re Already Late
-
With Nearly 500K Deliveries, Is Tesla Stock a Buy Before Q3 Earnings?
-
Tired of missing midday reversals? The FREE Barchart Brief newsletter keeps you in the know. Sign up now!
For the full year, analysts expect LDOS to report EPS of $11.41, up 11.8% from $10.21 infiscal 2024.
Over the past 52 weeks, LDOS stock hasclimbed 9.7%, trailing the S&P 500 Index’s ($SPX)13.5% gains and theTechnology Select Sector SPDR Fund’s (XLK)24% gainsover the same time frame.
On Aug. 5, Leidos Holdings’shares surged 7.5% following the release of its strongQ2 results and continued positive momentum for the subsequent six sessions. Its revenue rose 2.9% year over year to $4.3 billion, beating expectations. Non-GAAP EPS jumped 22.1% to $3.21, well above consensus, while free cash flow climbed 27.7% to $457 million, further strengthening investor confidence.
Analysts’consensus opinion on LDOS stockis reasonably bullish, with a “Moderate Buy” rating overall. Out of 16 analysts covering the stock, ten advise a “Strong Buy” rating, one suggests “Moderate Buy,” and five give a “Hold.” LDOS’ average analyst price target is $196.28, indicating a potential upside of 6.4% from the current levels.
On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originallypublished on Barchart.com
